Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
College students are now slightly less likely to experience severe depression, research shows – but the mental health crisis is far from over - 2Aspirin can prevent a serious pregnancy complication — but too few women get it, new report suggests
- 3Relentless rise in carbon pollution from fossil fuels slightly dampens climate-fighting hopes
- 46 Monetary Arranging Administrations for Your Necessities
- 5Kremlin: Russian troops conquer Pokrovsk after year of intense combat
- 6 US States for Fly Fishing
- New movies to watch this weekend: See 'The Running Man' in theaters, rent 'One Battle After Another,' stream 'Nobody 2' on Peacock
- 'The Real Housewives of Rhode Island' 1st teaser trailer unveiled: Which Bachelor Nation star is part of the cast? And when does it premiere?
- Collierville residents with no power as temperatures plunge
- World leaders, rights groups react to COP30 climate deal
- Manual for 6 Busssiness Class Flights
- A definitive Cruiser Standoff: Decision in favor of Your #1 Ride
- Investigating Free Cell Phones: What You Really want to Be aware
- Kids who get 2-month vaccines on time 7 times more likely to receive MMR shot: Study
